Final Agenda Now Available

Targeting Innate Immunity Congress
-先天性免疫標靶學會-
日期:2019年9月23-25日
地點:美國馬薩諸塞州劍橋市,Hyatt Regency Cambridge
Choose your language
Chinese
Japanese
Korean
English


關於Targeting Innate Immunity Congress

儘管過往有關先天性免疫研究的進展不多,近年已認識到其作為治療干預的具潛力工具的重要性。第1屆Targeting Innate Immunity Congress將齊聚相關意見領袖,包含產業專家、學術研究人員、醫師等,一同深入了解先天性免疫、以及如何利用其力量進行有效的免疫治療。為期2天的會議聚焦先天免疫治療領域的現況和新發展,如自然殺手細胞、巨噬細胞、樹狀細胞等。並討論先天免疫的作用機制、有效調節策略、腫瘤微環境影響等議題。您可在融洽的環境中和與會者交流創新想法、推動有意義的合作。在本學會中您可接觸到先天免疫社群最新成果,是透過交換情報和吸收新知拓展業務策略成果的重要基石。

2019主要演講者

Michael Klichinsky, PharmD, PhD
Co-Founder, Vice President, Carisma Therapeutics

Hans Klingemann, MD, PhD
Vice President, NantKwest, Inc.

Mark Lowdell, PhD
Director, Centre for Cell, Gene & Tissue Therapeutics, RFH; Professor, University College London

Shiladitya Sengupta, PhD
Principle Investigator, Harvard Medical School and Massachusetts Institute of Technology

RJ Tesi, MD
CEO, CMO, INmune Bio

Bob Valamehr, PhD
MBA, Chief Development Officer, Fate Therapeutics, Inc.



Technology Hub of the Boston Area
Cambridge, Massachusetts

The city of Cambridge, part of the Greater Boston area, is best known for being the home of two world-class universities, Harvard University and Massachusetts Institute of Technology (MIT). MIT is located in the heart of Technology Square, an area consisting of 7 major buildings forming a quadrangle with a combined 1 million-plus square feet of office, lab, and retail space. Surrounding Technology Square are other major tech and life science companies like Amgen, Inc., Akamai Technologies, Twitter, Novartis International AG, The Whitehead Institute, Schlumberger-Doll, and the Charles Stark Draper Laboratory. Cambridge prides itself on being a progressive community, enjoying both a rich history and an open eye toward the future. We hope you will join us to explore this charming city on the leading edge of technology.

Corporate Sponsors:
 
免費電子郵件通知服務